Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line

Journal of Cellular Physiology

Volumn 175, Issue 2, 1998, Pages 220-228

  Murakami, Yoshikazu ^a,b   Nakano, Shuji ^b   Niho, Yoshiyuki ^b   Hamasaki, Naotaka ^b   Izuhara, Kenji ^a,b  

^a NATIONAL INSTITUTE OF GENETICS   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN;

ARTICLE; CELL CULTURE; CELL LINE; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOCHEMISTRY; ENZYME ACTIVITY; GALLBLADDER CARCINOMA; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

DNA-BINDING PROTEINS; ENZYME ACTIVATION; GALLBLADDER NEOPLASMS; GENES, SRC; HUMANS; INTERFERONS; JANUS KINASE 3; NUCLEAR PROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; PROTEINS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFORMATION, GENETIC; TUMOR CELLS, CULTURED; TYK2 KINASE;

EID: 0031935185     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199805)175:2<220::AID-JCP12>3.0.CO;2-C     Document Type: Article

References (38)

1. Adams, S.L., Alwine, J.C., de Crombrugghe, B., and Pastan, I. (1979) Use of recombinant plasmids to characterize collagen RNAs in normal and transformed chick embryo fibroblasts. J. Biol. Chem., 254:4935-4938.
2. Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., Wei, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., and Kishimoto, T. (1994) Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell, 77:63-71.
3. Bedard, P.-A., Alcorta, D., Simmons, D.L., Luk, K.-C., and Erikson, R.L. (1987) Constitutive expression of a gene encoding a polypeptide homologous to biologically active human platelet protein in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 84:6715-6719.
4. Birchenall-Roberts, M.C., Ruscetti, F.W., Kasper, J., Lee, H.-D., Friedman, R., Geiser, A., Sporn, M.B., Roberts, A.B., and Kim, S.-J. (1990) Transcriptional regulation of the transforming growth facto β1 promoter by v-src gene products is mediated through the AP-1 complex. Mol. Cell. Biol., 10:4978-4983.
5. Brown, M.T., and Cooper, J.A. (1996) Regulation, substrates and functions of src. Biochim. Biophys. Acta, 1287:121-149.
6. Campbell, G., Yu, C., Jove, R., and Carter-Su, C. (1997) Constitutive activation of JAK1 in Src-transformed cells. J. Biol. Chem., 272:2591-2594.
7. Cao, X., Tay, A., Guy, G.R., and Tan, Y.H. (1996) Activation and association of STAT3 with Src in v-Src transformed cell lines. Mol. Cell. Biol., 16:1595-1603.
8. Carlesso, N., Frank, D.A., and Griffin, J.D. (1996) Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med., 183:811-820.
9. Chaturvedi, P., Sharma, S., and Reddy, E.P. (1997) Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol., 17:3295-3304.
10. Danial, N.N., Pernis, A., and Rothman, P.B. (1995) JAK-STAT signaling induced by the v-abl oncogene. Science, 269:1875-1877.
11. Fagan, J.B., Sobel, M.E., Yamada, K.M., de Crombrugghe, B., and Pastan, I. (1981) Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA. J. Biol. Chem., 256:520-525.
12. Fujii, M., Shalloway, D., and Verma, I.M. (1989) Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos. Mol. Cell. Biol., 9:2493-2499.
13. Fujishima, H., Nakano, S., Tatsumoto, T., Masumoto, N., and Niho, Y. (1996) Interferon alpha and gamma inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing src tyrosine kinase activity. Proc. Am. Assoc. Cancer Res., 37:425.
14. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., and Hirano, T. (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity, 5:449-460.
15. Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J.-F., Capiod, J.-C., Delobel, J., Weber-Nordt, R., Dusauter-Fourt, I., Dreyfus, F., Groner, B., and Prin, L. (1996) STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood, 87:1692-1697.
16. BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem., 271:31704-31710.
17. Izuhara, K., Heike, T., Otsuka, T., Yamaoka, K., Mayumi, M., Imamura, T., Niho, Y., and Harada, N. (1996) Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J. Biol. Chem., 271:619-622.
18. Joseph, C.K., Qureshi, S.A., Wallace, D.J., and Foster, D.A. (1992) MARCKS protein is transcriptionally down-regulated in v-Src-transformed BALB/c3T3 cells. J. Biol. Chem., 267:1327-1330.
19. Jove, R., and Hanafusa, H. (1987) Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol., 3:31-56.
20. Lengyel, P. (1993) Tumor-suppressor genes: News about the interferon connection. Proc. Natl. Acad. Sci. U.S.A., 90:5893-5895.
21. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, F., Lapidot, Z., Leeder, J.S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A., and Roifman, C.M. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379:645-648.
22. Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J.C., O'Shea, J.J., Franchini, G., and Leonard, W.J. (1995) Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science, 269:79-81.
23. Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., and Akira, S. (1996) STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. U.S.A., .93:3963-3966.
24. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., and Hirano, T. (1996) A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J., 15:3651-3658.
25. Ozaki, T., and Sakiyama, S. (1993) Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 90:2593-2597.
26. v-src and identification of a novel v-src-responsive unit. Mol. Cell. Biol., 13:3401-3414.
27. Qureshi, S.A., Cao, X., Sukhatme, V.P., and Foster, D.A. (1991) v-Src activates mitogen-responsive transcription factor Egr-1 via serum response elements. J. Biol. Chem., 266:10802-10806.
28. Schindler, C., and Darnell, J.E., Jr. (1995) Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu. Rev. Biochem., 64:621-651.
29. v-src. Mol. Cell. Biol., 16:481-486.
30. Stahl, N., Farruggella, T.J., Boulton, T.G., Zhong, Z., Darnell, J.E., Jr., and Yancopoulos, G.D. (1995) Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science, 267:1349-1353.
31. Sugano, S., Stoeckle, M.Y., and Hanafusa, H. (1987) Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein. Cell, 49:321-328.
32. Tatsumoto, T., Nakano, S., Shimizu, K., Ono, M., Esaki, T., Ohshima, K., and Niho, Y. (1995) Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene. Int. J. Cancer, 61:206-213.
33. Unkeless, J., Danø, K., Kellerman, G.M., and Reich, E. (1974) Fibrinolysis associated with oncogenic transformation. J. Biol. Chem., 249:4295-4305.
34. Watson, C., and Miller, W. (1995) Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer, 71:840-844.
35. Weber-Nordt, R.M., Egen, C., Wehinger, J., Ludwig, W., Gouilleur-Gruart, V., Mertelsmann, R., and Finke, J. (1996) Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood, 88:809-816.
36. Yu, C.-L., Meyer, D.J., Campbell, G.S., Larner, A.C., Carter-Su, C., Schwartz, J., and Jove, R. (1995) Enhanced DNA-binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein. Science, 269:81-83.
37. Zhong, Z., Wen, Z., and Darnell, J.E., Jr. (1994) Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science, 264:95-98.
38. Zong, C., Yan, R., August, A., Darnell, J.E., Jr., and Hanafusa, H. (1996) Unique signal transduction of Eyk: Constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J., 15:4515-4525.